Barriers and solutions to stepping down asthma treatment

<p>Asthma is a chronic airway disease with two characteristic features: (1) chronic airway inflammation (the most common eosinophilic airway inflammation) and (2) airway hyperresponsiveness (excessive airway constriction by normal triggers) [1]. Management of asthma requires long-term treatmen...

Full description

Saved in:
Bibliographic Details
Main Author: Nguyen-Ho Lam (Author)
Format: Book
Published: Open Journal of Asthma - Peertechz Publications, 2020-08-19.
Subjects:
Online Access:Connect to this object online.
Tags: Add Tag
No Tags, Be the first to tag this record!

MARC

LEADER 00000 am a22000003u 4500
001 peertech__10_17352_oja_000013
042 |a dc 
100 1 0 |a Nguyen-Ho Lam  |e author 
245 0 0 |a Barriers and solutions to stepping down asthma treatment 
260 |b Open Journal of Asthma - Peertechz Publications,   |c 2020-08-19. 
520 |a <p>Asthma is a chronic airway disease with two characteristic features: (1) chronic airway inflammation (the most common eosinophilic airway inflammation) and (2) airway hyperresponsiveness (excessive airway constriction by normal triggers) [1]. Management of asthma requires long-term treatment to achieve well-controlled symptoms and prevent the risk of exacerbation in future. Inhaled corticosteroid (ICS) is the mainstay therapy of asthma with strong evidences [2]. Nonetheless it is still the existence of gap in knowledge "what is the most appropriate dose of ICS to treat asthmatic patient?". </p> 
540 |a Copyright © Nguyen-Ho Lam et al. 
546 |a en 
655 7 |a Short Communication  |2 local 
856 4 1 |u https://doi.org/10.17352/oja.000013  |z Connect to this object online.